Qube Research & Technologies (QRT)
AXDX icon

Qube Research & Technologies (QRT)’s Accelerate Diagnostics AXDX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-35
Closed -$41 – 3310
2024
Q2 		$41 Hold
35
– – ﹤0.01% 3523
2024
Q1 		$35 Hold
35
– – ﹤0.01% 4234
2023
Q4 		$137 Hold
35
– – ﹤0.01% 4002
2023
Q3 		$201 Buy
+35
New +$235 ﹤0.01% 3730
2022
Q4 		– Sell
-1,687
Closed -$26K – 2461
2022
Q3 		$26K Sell
1,687
-949
-36% -$15.7K ﹤0.01% 2257
2022
Q2 		$26K Buy
+2,636
New +$23.3K ﹤0.01% 2231

Other funds holding AXDX

Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Cannell & Spears
Cannell & Spears New York $5.62B AUM 41.25% 1-Year Est. Return
OQS
Occudo Quantitative Strategies Fort Lauderdale, Florida $1.88B AUM 35.68% 1-Year Est. Return
TCI Wealth Advisors
TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AXDX Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Accelerate Diagnostics (AXDX) in Q3 2024, closing a stake of 35 shares — an estimated $41 sold.

Qube Research & Technologies (QRT) first reported a position in AXDX in Q2 2022 and held it in 6 quarters. The position peaked at $26K in Q3 2022. 46 funds tracked by Wall St. Rank hold AXDX as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Accelerate Diagnostics position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 35 Accelerate Diagnostics shares in Q3 2024, an estimated $41.
  • Qube Research & Technologies (QRT) first reported a position in Accelerate Diagnostics in Q2 2022 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Accelerate Diagnostics position peaked at $26K in Q3 2022.
  • 46 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.